Skip to content

MICRO-SURG: Subgingival Microbiome in Peri-Implantitis, Regenerative, and Resective Periodontal Surgery

MICRO-SURG: Investigation of Subgingival Microbiome Changes Following Surgical Peri-Implantitis Therapy, Regenerative Periodontal Surgery, and Resective Periodontal Surgery Using Next-Generation Sequencing

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07414498
Acronym
MICROSURG
Enrollment
84
Registered
2026-02-17
Start date
2026-02-01
Completion date
2026-04-01
Last updated
2026-02-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Periodontitis, Periimplantitis

Keywords

Subgingival Microbiome, Periodontal Surgery, Regenerative Surgery, Resective Surgery, Peri-Implantitis Surgery, Next-Generation Sequencing, 16S rRNA Sequencing, Microbiome Analysis, SMDI

Brief summary

This clinical study investigates how the subgingival microbiome changes after three different periodontal and peri-implant surgical procedures: (1) resective periodontal surgery, (2) regenerative periodontal surgery, and (3) peri-implantitis surgery. The aim is to characterize microbial shifts associated with these commonly used surgical treatments and to determine whether the type of surgery influences the recovery or disruption of the subgingival ecosystem. Adult patients with periodontitis or peri-implantitis will receive the procedure indicated for their condition. Subgingival plaque samples will be collected at baseline and at defined postoperative follow-up intervals. Microbiome analysis will be performed using next-generation sequencing (NGS), and microbial changes will be evaluated with the Subgingival Microbial Dysbiosis Index (SMDI). Insights from this study may help improve prevention, diagnostics, and treatment strategies for periodontal and peri-implant diseases.

Interventions

PROCEDUREResective Periodontal Surgery

Apically repositioned full-thickness mucoperiosteal flap with resective surgical treatment of periodontal defects. Includes removal of inflamed tissue and recontouring of osseous structures according to clinical indication. Microbiome samples are taken pre-, intra- and postoperatively.

Regenerative periodontal therapy including the use of autogenous bone, membranes, and/or bone substitute materials for periodontal regeneration.

PROCEDURESurgical Peri-implantitis Therapy

Surgical intervention for peri-implantitis including surgical access flap, defect debridement, implant surface decontamination, and resective or regenerative procedures as clinically indicated.

Sponsors

University Hospital Muenster
Lead SponsorOTHER
dfg
CollaboratorUNKNOWN

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

Participants are assigned to one of three parallel surgical intervention groups: (i) resective periodontal surgery, (ii) regenerative periodontal surgery, or (iii) peri-implantitis surgery. No crossover between groups is planned.

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Age 18 years or older * Confirmed diagnosis of Peri-implantitis (for the peri-implantitis surgery arm), or Stage III/IV periodontitis (for the periodontal surgery arms) * Indication for surgical therapy corresponding to the assigned study arm * Ability to understand the study procedures and provide written informed consent * Adequate oral hygiene (API/SBI according to the clinician's judgment) * Willingness and ability to attend all follow-up visits * Willingness to provide salivary and subgingival plaque samples for microbiome analyses (NGS, SMDI)

Exclusion criteria

* Systemic conditions contraindicating oral surgical procedures * Severe systemic diseases (e.g., uncontrolled diabetes mellitus, immunosuppressive disorders) * Use of systemic antibiotics within the previous 3 months * Active COVID-19 infection at the time of surgery * Pregnancy or breastfeeding * Drug or alcohol abuse * Smoking more than 10 cigarettes per day * Known allergies to materials used in the assigned intervention (e.g., local anesthetics, sutures, membranes, bone grafting materials) * Participation in another clinical study within the previous 30 days * Acute oral infections that contraindicate participation * Inability or unwillingness to comply with all follow-up appointments Lack of capacity to provide informed consent

Design outcomes

Primary

MeasureTime frameDescription
Change in Subgingival Microbiome Composition After Periodontal and Peri-implant SurgeryBaseline (preoperative), intraoperative sampling (Day 0), 1 week, 4 weeks, and 12 weeks postoperativelyAssessment of changes in the subgingival and peri-implant microbiome before, during, and after surgical treatment. Microbiome samples are collected at standardized time points and analyzed using next-generation sequencing (NGS), including 16S rRNA gene sequencing and Structure Microbial Diversity Index (SMDI). The primary outcome reflects quantitative and qualitative microbial shifts induced by resective periodontal surgery, regenerative periodontal surgery, or peri-implantitis surgery.

Secondary

MeasureTime frame
Clinical attachment level (CAL) gainBaseline and 12 weeks postoperatively
Probing depth (PD) reductionBaseline (preoperative) and 12 weeks postoperatively
Bleeding on probingBaseline (preoperative) and 12 weeks postoperatively
Implant pocket reductionBaseline (preoperative) and 12 weeks postoperatively

Countries

Germany

Contacts

CONTACTBenjamin Ehmke, Univ. -Prof. Dr. med. dent.
ehmke@uni-muenster.de+4902518347059
CONTACTDaniel Hagenfeld, PD Dr. med. dent.
Daniel.hagenfeld@ukmuenster.de+492518345092
PRINCIPAL_INVESTIGATORBenjamin Ehmke, Univ. Prof. Dr. med. dent.

Clinic for Periodontology and Conservative Dentistry, University of Münster

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 18, 2026